Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Prognostic and clinicopathological insights of phosphodiesterase 9A gene as novel biomarker in human colorectal cancer

Fig. 5

mRNA expression analysis of PDE9A based on different variables for Colon Adenocarcinoma (COAD) patients. Expression of PDE9A in COAD based on (a) sample types, (b) individual cancer stages, (c) patient race, (d) patient gender, (e) patient weight, (f) patient weight, (g) tumor histological subtype, (h) nodal metastasis status, and (i)T53 mutation status

Back to article page